Preparation method of anagrelide derivative

A technology for derivatives and substances, applied in the field of drug synthesis, can solve the problems of unreported synthetic methods of anagrelide derivatives, and achieve the effects of good environmental protection effect, reasonable process design, and easy availability of raw materials

Inactive Publication Date: 2018-02-23
TLC NANJING PHARMA RANDD CO LTD
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The synthesis of anagrelide derivatives and related pharmacology and pharmacokinetic studies on anagrelide derivatives can provide test samples for anagrelide research and quality testing, and anagrelide derivatives also have good Medicinal prospects, but there is no report on the synthetic method of anagrelide derivatives

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of anagrelide derivative
  • Preparation method of anagrelide derivative
  • Preparation method of anagrelide derivative

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0023] Preparation of Compound II: Suspend 1,2,3,4-tetrachlorobenzene in 40mL 98% concentrated sulfuric acid, add a mixed solution of 65% concentrated nitric acid and 9.17mL 98% concentrated sulfuric acid at a certain After stirring at high temperature for 3 hours, the reaction solution changed from a white suspension to a yellow suspension. Pour the reaction solution directly into 200g of ice, add 200mL of water, extract twice with 200mL of ethyl acetate, combine the organic phases, wash with 200mL of water, then wash with 200mL of saturated sodium bicarbonate, dry the organic phase, and evaporate to dryness The ratio of the amount of yellow solid compound II, 1,2,3,4-tetrachlorobenzene to concentrated nitric acid, and the experimental data of the reaction solvent are as follows:

[0024]

[0025] The screening experiment data of optimal reaction temperature are as follows:

[0026]

[0027] Preparation of Compound III: Dissolve 0.07 mol of Compound II in 9.6 mL of sol...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method of an anagrelide derivative, and belongs to the field of pharmaceutical synthesis. The method is reasonable in process design, high in operability, relatively mild in reaction condition and high in yield, and can realize industrial production. According to the preparation method of the anagrelide derivative, synthesis of the anagrelide derivative is realized by taking 1,2,3,4-tetrachlorobenzene as a raw material through six-step reaction. The anagrelide derivative prepared through the preparation method provides an important basis for scientific evaluation of the quality, the safety and the efficacy of anagrelide; furthermore, the anagrelide derivative is high in pharmacological activity, can be prepared into drugs for treating thrombocytosis caused by various reasons, and has an important application value.

Description

technical field [0001] The invention belongs to the field of drug synthesis, in particular to a preparation method of anagrelide derivatives. Background technique [0002] Platelet aggregation inhibitor Anagrelide is an oral anti-platelet aggregation drug, a cyclophosphine (cMAP) phosphodiacylase (PDE) inhibitor, chemical name 6,7-dichloro-l,2,3,5 -Tetrahydroimidazo[2,1-b]quinazolin-2-(3H)-one, trade name Agrylin, was developed by Roberts Phnaajeeutieals in the United States, and was approved to be listed in the United States in July 1997. The drug has the advantages of strong selectivity, no leukopenia, anemia, and serious side effects of leukemia. At present, it is used to treat thrombocytosis caused by essential thrombocythemia and myeloproliferative diseases, which can reduce the number of platelets in patients by 50% within a week, and the effective rate is over 80%. It can even treat patients who are ineffective after hydroxyurea treatment. Within the therapeutic dos...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D487/04
CPCC07D487/04
Inventor 吴文超徐庶张池崔希林
Owner TLC NANJING PHARMA RANDD CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap